Authors

• Naris Nilubol (ORCID: https://orcid.org/0000-0002-7348-7804)
• Philip Eclarinal (ORCID: https://orcid.org/0000-0002-3115-7495)
• Barış Türkbey (ORCID: https://orcid.org/0000-0003-0853-6494)
• Fahmida Haque (ORCID: https://orcid.org/0000-0003-2023-2258)
• Charalampos S. Floudas (ORCID: https://orcid.org/0000-0002-0020-237X)
• Stephanie A. Harmon (ORCID: https://orcid.org/0000-0002-2507-2399)
• Evrim Türkbey (ORCID: https://orcid.org/0000-0002-5216-3528)
• Jorge A. Carrasquillo (ORCID: https://orcid.org/0000-0002-8513-5734)
• Esther Mena (ORCID: https://orcid.org/0000-0003-0015-0597)
• Frank I. Lin (ORCID: https://orcid.org/0000-0003-3539-1454)
• Liza Lindenberg (ORCID: https://orcid.org/0000-0002-8514-0648)
• Peter L. Choyke (ORCID: https://orcid.org/0000-0003-1086-8826)

Institutions

• National Institutes of Health (US)
• National Cancer Institute (US)
• National Institutes of Health Clinical Center (US)

Publication Details

Journal

EJNMMI Research

Published

2024-11-05

DOI

https://doi.org/10.1186/s13550-024-01168-5

Citations

4

Primary Topic

Adrenal and Paraganglionic Tumors

Type

article

Field-Weighted Citation Impact

2.29

Funders

• National Institutes of Health